Cargando…
Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application
The ACR/EULAR classification criteria for systemic sclerosis (SSc) entail three autoantibodies: anti-centromere antibodies (ACA), anti-topoisomerase I antibodies (ATA), and anti-RNA-polymerase III antibodies (ARA). The importance of ACA and ATA in the classification criteria is evidence based, but t...
Autores principales: | Damoiseaux, Jan, Potjewijd, Judith, Smeets, Ruben L., Bonroy, Carolien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741499/ https://www.ncbi.nlm.nih.gov/pubmed/35028553 http://dx.doi.org/10.1016/j.jtauto.2022.100141 |
Ejemplares similares
-
Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up
por: Bonroy, Carolien, et al.
Publicado: (2022) -
Autoantibodies in the criteria of autoimmune diseases: is it sufficient to know that the test is positive?
por: Damoiseaux, Jan
Publicado: (2022) -
New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic Sclerosis
por: Lande, Roberto, et al.
Publicado: (2021) -
Favorable long term effects of intensified immunosuppression combined with therapeutic plasma exchange in patients with early-onset progressive systemic sclerosis-related interstitial lung disease()
por: Potjewijd, J., et al.
Publicado: (2022) -
Autoantibodies to dsDNA in the diagnosis, classification and follow-up of patients with systemic lupus erythematosus
por: Damoiseaux, Jan, et al.
Publicado: (2023)